Unpacking Medical Interventions for Obesity with Dr. Randy Seeley
Episode Overview
Obesity is increasingly understood as a biological issue requiring medical treatments. Bariatric surgery involves physiological changes that help regulate body weight. New anti-obesity drugs like Ozempic and Wegovy show significant promise. Safety and long-term impacts are crucial considerations for these treatments. Understanding leptin has been key to developing effective obesity therapies.
The magic here is that we have got people to reduce their intake, and they're less hungry while they're losing the weight
Ready to dive into the complexities of obesity treatment? In this episode of 'Lobes and Robes', Dr. Randy Seeley, a renowned expert from the University of Michigan, sheds light on the fascinating world of medical interventions for obesity. With hosts Susan Carl and Dr. Terry Davidson leading the discussion, you'll get a front-row seat to the latest advancements in both surgical and pharmacological treatments. Dr.
Seeley shares his journey through 30 years of research, highlighting how our understanding of obesity as a biological issue has evolved. He discusses the groundbreaking discovery of leptin and its impact on developing new therapies. You'll learn about bariatric surgery's physiological changes and the rise of new anti-obesity drugs like Ozempic and Wegovy. The conversation is not just scientific but also deeply practical, addressing common concerns about safety, effectiveness, and long-term impacts.
Whether you're curious about how these treatments work or their implications for public health, this episode offers valuable insights. Don't miss out on this enlightening discussion that could change your perspective on obesity treatment.